Skip to main content

Table 1 Summary chemotherapy and immunotherapy agents received by patient 1

From: Predictive role of PD-L1 expression in the response of renal Medullary carcinoma to PD-1 inhibition

Treatments Duration
Cisplatin, paclitaxela, gemcitabine Six cycles
Nivolumab 28 cycles (56 weeks)b
Ipilimumab 2 cycles (6 weeks)c
  1. aPaclitaxel was stopped after first cycle due to grade 3 toxicity
  2. bAt the time of submission of this manuscript, 28 cycles were completed but nivolumab will be continued
  3. cAt the time of submission of this manuscript, 2 cycles were given and will be continued for 2 more cycles